Prostate cancer screening characteristics in men with BRCA1/2 mutations attending a high-risk prevention clinic

INTRODUCTION: The prostate-specific antigen (PSA) era and resultant early detection of prostate cancer has presented clinicians with the challenge of distinguishing indolent from aggressive tumours. Mutations in the BRCA1/2 genes have been associated with prostate cancer risk and prognosis. We descr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Can Urol Assoc J
Egile Nagusiak: Walker, Richard, Louis, Alyssa, Berlin, Alejandro, Horsburgh, Sheri, Bristow, Robert G., Trachtenberg, John
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Canadian Medical Association 2014
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4250241/
https://ncbi.nlm.nih.gov/pubmed/25485004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.1970
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak